Your browser doesn't support javascript.
loading
Synthesis and SAR of novel benzoxaboroles as a new class of ß-lactamase inhibitors.
Xia, Yi; Cao, Kathy; Zhou, Yasheen; Alley, M R K; Rock, Fernando; Mohan, Manisha; Meewan, Maliwan; Baker, Stephen J; Lux, Sarah; Ding, Charles Z; Jia, Guofeng; Kully, Maureen; Plattner, Jacob J.
Affiliation
  • Xia Y; Anacor Pharmaceuticals, Inc., 1020 E. Meadow Circle, Palo Alto, CA 94303, USA. axia@anacor.com
Bioorg Med Chem Lett ; 21(8): 2533-6, 2011 Apr 15.
Article in En | MEDLINE | ID: mdl-21392987
ABSTRACT
A new class of benzoxaborole ß-lactamase inhibitors were designed and synthesized. 6-Aryloxy benzoxaborole 22 inhibited AmpC P99 and CMY-2 with K(i) values in the low nanomolar range. Compound 22 restored antibacterial activity of ceftazidime against Enterobacter cloacae P99 expressing AmpC, a class C ß-lactamase enzyme. The SAR around the arylbenzoxaboroles, which included the influence of linker and substitutions was also established.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Benzoxazoles / Boron Compounds / Enzyme Inhibitors / Beta-Lactamase Inhibitors / Anti-Bacterial Agents Language: En Year: 2011 Type: Article

Full text: 1 Database: MEDLINE Main subject: Pyrazines / Benzoxazoles / Boron Compounds / Enzyme Inhibitors / Beta-Lactamase Inhibitors / Anti-Bacterial Agents Language: En Year: 2011 Type: Article